Karl Scheidt, based in Evanston, IL, US, is currently a Co-Founder at Riptide Therapeutics, bringing experience from previous roles at Northwestern University, Third Coast Therapeutics, Harvard University and Indiana University. Karl Scheidt holds a 1999 - 2002 NIH Fellow in Chemistry @ Harvard University. With a robust skill set that includes Science, Research, Statistics, Microsoft Excel, Strategy and more, Karl Scheidt contributes valuable insights to the industry. Karl Scheidt has 1 email and 1 mobile phone number on RocketReach.